Read + Share
Amedeo Smart
Independent Medical Education
Abramson JS, Palomba ML, Gordon LI, Lunning MA, et al. Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study. Lancet 2020;396:839-852.PMID: 32888407
Email
LinkedIn
Facebook
Twitter
Privacy Policy